Tumor-Associated Antigens and Immunity in Prostatic Carcinoma

Adenocarcinoma of the prostate, with an incidence of death in males second only to bronchogenic cancer (32), difficulty in early diagnosis and controversy over therapy (20), presents a continuing dilemma to the male populace requisite of more effective means of diagnosis, prognosis, and therapy.